Zelira Therapeutics Ltd Cash Flow Reinvestment Rate

Latest as of December 2015: 0.23x

Zelira Therapeutics Ltd cash flow reinvestment rate. Zelira Therapeutics Ltd (ZLD) has a Cash Flow Reinvestment Rate of 0.23x as of December 2015, reinvesting AU$36.80K (capex AU$36.80K ) from operating cash flow of AU$159.61K. Explore how well can Zelira Therapeutics Ltd service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.23x

(Capex + Investments) / Operating CF

Total Reinvested

AU$36.80K

Capex + Investments

Operating Cash Flow

AU$159.61K

AUD

Capital Expenditures

AU$36.80K

AUD

Cash Flow Reinvestment Rate of Zelira Therapeutics Ltd (2011–2011)

Cash flow reinvestment rate of Zelira Therapeutics Ltd from 2011 to 2011. Historical reinvestment intensity for Zelira Therapeutics Ltd across 1 annual periods. Explore Zelira Therapeutics Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Zelira Therapeutics Ltd Cash Flow Reinvestment Rate by Year (2011–2011)

Zelira Therapeutics Ltd cash flow reinvestment rate by year from 2011 to 2011. Year-by-year capital reinvestment analysis for Zelira Therapeutics Ltd. For the full cash flow conversion analysis, see Zelira Therapeutics Ltd (ZLD) cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2011	0.14x	AU$13.95K	AU$101.92K	AU$13.95K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow